Laboratorios Farmacéuticos Rovi, S.A.

Tweet this page
<
2024
>
Registration as it was on 04 Mar 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

10,000€ - 24,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

0.5 Fte (5)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Laboratorios Farmacéuticos Rovi, S.A.

    EU Transparency Register

    399928552868-09 First registered on 15 Feb 2024

    Goals / Remit

    ROVI works for the well-being of society and to improve the quality of life and patient care, promoting human health through the research, manufacturing, marketing and distribution of medicines and other healthcare products

    ROVI is actively seeking strategic opportunities to market other companies’ products (in-licensing) in Spain and Portugal, either on an exclusive basis or under a system of co-marketing, co-branding or co-promotion and acquisition of products
    We are striving to reinforce our contract manufacturing operations by acquiring new customers who help to maximize the potential of both our two injectables plants and the solid oral forms plant
    Entering into agreements granting marketing rights for our proprietary molecules outside Spain
    Establishing co-operation on R&D projects with companies and/or universities

    Main EU files targeted

    • Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006

    • Proposal for a Regulation laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency (https://health.ec.europa.eu/publications/proposal-regulation-laying-down-union-procedures-authorisation-and-supervision-medicinal-products_en)

    • Proposal for a Directive on the Union code relating to medicinal products for human use (https://health.ec.europa.eu/publications/proposal-directive-union-code-relating-medicinal-products-human-use_en)

    • International agreement on pandemic prevention and preparedness (https://www.consilium.europa.eu/en/policies/coronavirus/pandemic-treaty/)

    • Europe's Beating Cancer Plan

    • EU SoHO Platform

    Address

    Head Office
    Julián Camarillo, 35
    Madrid
    SPAIN
    EU Office
    Julián Camarillo, 35
    Madrid
    SPAIN

    Website

  • People

    Total lobbyists declared

    5

    Employment timeLobbyists
    10%5

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    Rovi does not have representantives in Brussels. The registration in the transparency register responds to its participation in the Critical Medicines Alliance, that is why we have this low level of engament.

    We may hire consultancy services from time to time, so we have included that too.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    • Biosim (Asociación Española de Medicamentos Biosimilares), que es la asociación española que engloba a las empresas farmacéuticas de medicamentos biosimilares.
    • Fundación IDIS, entidad que aglutina al sector sanitario privado orientado a poner en valor la sanidad privada (es multidisciplinar, ya que forman parte laboratorios, aseguradoras, grupos de hospitales privados, etc).
    • Farmaindustria
    • AKG en Alemania
    • Apifarma en Portugal
    • EFPIA
    • Corporación Tecnológica CTA

    Member organisations

    - Director de Registros de Laboratorios Farmacéuticos ROVI, S.A.
    - Técnico de Registros de Laboratorios Farmacéuticos ROVI, S.A.
    - Responsable de Registros de Laboratorios Farmacéuticos ROVI, S.A.
    - Director de Compliance de Laboratorios Farmacéuticos ROVI, S.A.

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    10,000€ - 24,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    10,000€ - 24,999€

    Other financial info

    Durante el año 2022, ROVI registró subvenciones estatales y autonómicas por importe de €2,1 millones.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    El tema de las reuniones fue presentar a Rovi como una compañía farmacéutica española líder en su campo, así como sus principales líneas de acción y compromiso con la política europea de salud a través de su participación en el IPCEI de salud:
    https://www.cdti.es/ayudas/proyecto-importante-de-interes-comun-europeo-ipcei-de-salud

    Listado de las reuniones mantenidas:
    Comisión Europea con el director general del Servicio Jurídico y con el director general adjunto de mercado interior, industria y PYME (DG Grow)
    Parlamento Europeo con el miembro de la Comisión de Medio Ambiente, Salud Pública y Seguridad Alimentaria (ENVI), con el miembro de la Comisión de ENVI y suplente, con el miembro de la Comisión de Mercado Interior y Protección del Consumidor (IMCO) y con la asistente parlamentaria del miembro de la Comisión IMCO.

    El BEI y ROVI firman un acuerdo, para apoyar las actividades de I+D+i ligadas a la tecnología de liberación prolongada de medicamentos ISM®.

    Other activities

    None declared

  • Meetings

    Meetings

    None declared

Download this datacard